ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد

2017 World Health Organization (WHO) classification and grading of pancreatic neuroendocrine neoplasms (PanNENs)

2017 World Health Organization (WHO) classification and grading of pancreatic neuroendocrine neoplasms (PanNENs)
Classification/grade Ki-67 proliferation index* (%) Mitotic index*
Well-differentiated PanNENs: Pancreatic neuroendocrine tumours (PanNETs)
PanNET G1 <3 <2
PanNET G2 3 to 20 2 to 20
PanNET G3 >20 >20
Poorly differentiated PanNENs: Pancreatic neuroendocrine carcinomas (PanNECs)
PanNEC >20 >20
Small cell type    
Large cell type    
Mixed neuroendocrine-non-neuroendocrine neoplasm
* The Ki-67 proliferation index is based on the evaluation of ≥500 cells in areas of higher nuclear labelling (so-called hotspots). The mitotic index is based on the evaluation of mitoses in 50 high-power fields (0.2 mm2 each) in areas of higher density, and is expressed as mitoses per 10 high-power fields (2.0 mm2). The final grade is determined based on whichever index (Ki-67 or mitotic) places the tumour in the highest grade category. For assessing Ki-67, casual visual estimation (eyeballing) is not recommended; manual counting using printed images is advocated.
Reference:
  1. WHO Classification of Tumours Editorial Board. Endocrine tumours. In: WHO Classification of Tumours, 5th ed, International Agency for Research on Cancer 2022.

Adapted from WHO Classification of Tumours of Endocrine Organs, 4th ed, Vol. 10, Lloyd RV, Osamura RY, Klöppel G, Rosai J (Eds), Neoplasms of the neuroendocrine pancreas, page 211. Copyright © 2017 International Agency for Research on Cancer. https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Endocrine-Organs-2017 (Accessed on April 26, 2024).

Graphic 115945 Version 4.0